Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review.
about
Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer.Nuclear S100A7 is associated with poor prognosis in head and neck cancer.Guggulsterone targets smokeless tobacco induced PI3K/Akt pathway in head and neck cancer cellsOverexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.Oral Mucosal Lesions Associated with Smokers and Chewers - A Case-Control Study in Chennai Population.Relationship between oral cancer and implants: clinical cases and systematic literature reviewSmokeless tobacco and risk of head and neck cancer: evidence from a case-control study in New England.Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.Smokeless tobacco: a gateway to smoking or a way away from smoking.An update on the clinical pathology of oral precancer and cancer.Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.Clinical significance of TC21 overexpression in oral cancer.PI3K-AKT-mTOR pathway proteins are differently expressed in oral carcinogenesis.Brand specific responses to smokeless tobacco in a rat lip canal model.Human papilloma virus associated head and neck cancer: A PCR based study.How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India.Coexpression of p53 and Ki 67 and lack of c-erbB2 expression in oral leukoplakias in India.Immunoexpression of tenascin as a predictor of the malignancy potential of oral leukoplakia associated with a tobacco habit.
P2860
Q33567362-E7734D0A-51A6-490D-B311-FFC40FB7F2A7Q33651153-DE517FF3-DA54-4C6E-95D9-776A7DE6BA13Q33839529-83774D08-7CD0-4F00-A20E-D0E9F7035B5CQ33900846-1D301FDE-2837-4FC5-9953-D0ACE97FEB98Q36068275-686FBD92-ED48-42E0-9937-9722783C6AEDQ36250645-F7E01AC2-C7FF-4E98-B4E1-E59662BF9D32Q36553606-3456EA65-B95C-46E4-9094-BFCF9E892D18Q37461637-DC7E58B3-B16F-4FF7-A462-0D0D94DDA5F8Q37551886-B994C9BA-090A-4304-A77D-5B78EE9EBCC4Q38100179-B5EE189B-B238-46C1-9D1A-C4B4980F7836Q39696941-13876903-5D17-48FF-92F4-062BF2F6E0BEQ39757993-7B506501-2BFE-4927-880D-A615A1543EDCQ40486150-37BDCF8B-0B17-4D3E-8AE8-897EBB016380Q42965907-A5E5A7D4-3FE2-44F2-AF80-81CCBC4DEE98Q43600041-60D7E9FD-3119-4D24-BE2B-D362DB789298Q44073007-8CC2D9DC-D319-4052-9DFE-6952C709597FQ45252449-0297A177-6078-4834-B95C-5363239D93DEQ53269834-DC0F8E17-2E25-4B2E-B03F-DD3E93A125D5Q53558609-EFB4B0DC-F304-4DB0-A7A6-B8E886B9FD60
P2860
Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco--a review.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Clinical, pathological, cellul ...... l smokeless tobacco--a review.
@ast
Clinical, pathological, cellul ...... l smokeless tobacco--a review.
@en
type
label
Clinical, pathological, cellul ...... l smokeless tobacco--a review.
@ast
Clinical, pathological, cellul ...... l smokeless tobacco--a review.
@en
prefLabel
Clinical, pathological, cellul ...... l smokeless tobacco--a review.
@ast
Clinical, pathological, cellul ...... l smokeless tobacco--a review.
@en
P2860
P1476
Clinical, pathological, cellul ...... al smokeless tobacco--a review
@en
P2093
P2860
P356
10.1111/J.1600-0714.2007.00496.X
P577
2007-02-01T00:00:00Z